查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1715475

预填充式注射器市场：按类型、材料类型、设计、产量、製造方法、应用和分销管道 - 2025-2030 年全球预测

Prefilled Syringes Market by Type, Material Type, Design, Volume, Manufacturing Method, Application, Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计预填充式注射器市场规模在 2024 年将达到 152.3 亿美元，在 2025 年将达到 163.4 亿美元，预计复合年增长率为 7.71%，到 2030 年将达到 237.8 亿美元。

主要市场统计数据
基准年2024年 152.3亿美元
预计2025年 163.4亿美元
预测年份 2030 237.8亿美元
复合年增长率（%） 7.71%

在技​​术创新和加强患者照护的强烈推动下，全球预填充式注射器市场正以前所未有的速度发展。近年来，预填充式注射器的采用率越来越高，因为它们比传统的基于管瓶的给药机制具有明显的优势。预填充式注射器不仅可以提高剂量准确性，还可以最大限度地降低与污染和用药错误相关的风险。

在如此动态的市场环境中，安全和效率的双重挑战备受相关人员关注。这些设备越来越被视为医疗保健服务的重要组成部分，因为它们解决了传统方法的后勤挑战。随着研发推动产品创新，製造商目前正专注于注射器设计、材料和製造流程的进步。对具有成本效益且技术先进的解决方案的需求正在推动该市场的竞争力。

本执行摘要概述了将重新定义预填充式注射器未来的关键市场动态、技术进步和发展趋势。该分析涉及市场的各个方面，并强调了影响当前情况和未来成长前景的关键因素。

预填充式注射器市场的变革

近年来，预填充式注射器市场发生了变革性的变化，证明该产业已准备好迎接变革和创新。製造技术的进步，加上药物传输机制的进步，显着提高了注射器的性能。特别是，技术创新正在解决与无菌性、易用性和环境永续性相关的挑战。先进材料的整合使得预填充式注射器与更广泛的药物相容，从而扩大其在各个治疗领域的效用。

向无针和传统技术的转变表明了该行业致力于改善患者体验和安全。製造商正在投资研究，重点是克服现有设计的局限性，这推动了从传统玻璃向先进塑胶和混合设计的转变。这项进步不仅反映了对更易于使用的产品的需求，也凸显了法规的变化。世界各地的监管机构都建议加强安全通讯协定，并要求公司升级生产线并遵守严格的品质标准。

此外，製造和供应链管理的数位化整合可以实现即时监控和品管，确保最终产品符合严格的规格。市场应对力这些变化，这一点从为满足新的临床需求而推出的大量产品中可以看出。因此，预填充式注射器市场正从主要的被动姿态转向主动策略，以预测未来的医疗保健挑战。

预填充式注射器的关键细分洞察

对预填充式注射器市场的详细細項分析揭示了一个由多种因素驱动的复杂框架。首先，基于类型的评估揭示了传统预填充式注射器和无针替代品之间的二分法。这些变化满足了不同的临床需求，并根据应用提供了独特的优势。根据材质类型，注射器可分为玻璃注射器和塑胶注射器。对于玻璃，可以考虑硼硅酸玻璃和钠钙玻璃，对于塑料，可以考虑透明聚对苯二甲酸乙二醇酯和聚丙烯。

从设计来看，分为双室型和单室型。另一方面，单室系统通常采用整合式套环和柱塞或标准柱塞设计，以确保一致性和可靠性。基于体积的细分进一步将市场分为 1ml-5ml、1ml 以下和 5ml 以上范围，每种范围均针对特定的剂量要求和患者属性进行客製化。

此外，製造方法提供了对底层技术流程的洞察，包括吹灌封技术、挤压和射出成型。这种分类不仅突显了製造技术的多样性，也突显了这些方法对产品可扩展性和成本结构的影响。另一个关键的细分维度是应用领域，肿瘤学、风湿病学、疫苗接种等治疗领域推动市场需求。透过区分化疗药物和免疫治疗方法，进一步分析肿瘤产品。风湿病学按应用细分，例如抗发炎注射和缓解疾病药物，而疫苗接种则分为成人、儿科和旅行等类别。

最后，分销通路细分突显了这些产品到达最终用户的不同途径。医院、诊所、网路药局和零售药局共同构成一个支持市场成长的动态网路。每个细分维度都描绘出了市场多面性的全面图景，突显了有针对性的创新和策略投资的机会。

目录

第一章 引言

第二章调查方法

第三章执行摘要

第四章 市场概述

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 自我用药需求增加，用药错误减少
      • 慢性病盛行率的上升推动了医疗保健领域对预填充式注射器的需求
      • 疫苗接种工作和意识提高
    • 限制因素
      • 预填充式注射器低温运输储运困难点
    • 机会
      • 家庭医疗保健服务的扩展推动了对易于使用的预填充式注射器解决方案的需求。
      • 新兴市场的医疗保健意识和支出不断提高
    • 任务
      • 确保不同地区的预填充式注射器的品质和安全标准一致
  • 市场区隔分析
    • 类型：传统预填充式注射器由于其成熟的市场地位，渗透率较高
    • 分销管道：准确的剂量和安全特性正在推动医院和诊所对预填充式注射器的需求。
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社会
    • 技术的
    • 合法的
    • 环境

第六章预填充式注射器市场（依类型）

  • 常规预填充式注射器
  • 无针预填充式注射器

第七章预填充式注射器市场（依材料类型）

  • 玻璃
    • 硼硼硅酸玻璃
    • 钠钙玻璃
  • 塑胶
    • 透明聚对苯二甲酸乙二醇酯
    • 聚丙烯

第八章预填充式注射器市场设计

  • 双腔
    • 可爆破密封
    • 双重密封设计
  • 单室
    • 彩色柱塞集成
    • 标准柱塞

第九章预填充式注射器市场（依销售量）

  • 1ml～5ml
  • 小于1毫升
  • >5ml

第 10 章预填充式注射器市场（依製造方法）

  • 吹灌封技术
  • 挤压
  • 射出成型

第11章预填充式注射器市场（依应用）

  • 肿瘤学
    • 化疗药物
    • 免疫疗法
  • 风湿病学
    • 消炎注射剂
    • 缓解疾病的药物
  • 疫苗接种
    • 成人疫苗接种
    • 儿童疫苗接种
    • 旅行疫苗接种

第十二章预填充式注射器市场（依通路）

  • 医院和诊所
  • 网路药局
  • 零售药局

13. 美洲预填充式注射器市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

14. 亚太地区预填充式注射器市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

15. 欧洲、中东和非洲预填充式注射器市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十六章竞争格局

  • 2024年市场占有率分析
  • 2024年FPNV定位矩阵
  • 竞争情境分析
  • 战略分析与建议

公司名单

  • AbbVie Inc.
  • AptarGroup, Inc.
  • Baxter International, Inc.
  • Becton, Dickinson and Company
  • Boehringer Ingelheim Pharmaceuticals, Inc
  • Catalent, Inc. by Novo Holdings A/S
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • Fresenius Kabi AG
  • Gerresheimer AG
  • GlaxoSmithKline plc
  • Janssen Pharmaceuticals, Inc. by Johnson & Johnson
  • Mylan NV by Viatris Inc.
  • Nipro Europe Group Companies
  • Novartis AG
  • Pfizer, Inc.
  • Samsung Bioepis
  • Sanofi SA
  • SCHOTT Pharma
  • Shandong Weigao Group Medical Polymer Company Limited
  • SHL Medical AG
  • Stevanato Group
  • Terumo Medical Corporation
  • Teva Pharmaceutical Industries Ltd.
  • West Pharmaceutical Services, Inc.
  • Ypsomed AG
Product Code: MRR-030EE48515C9

The Prefilled Syringes Market was valued at USD 15.23 billion in 2024 and is projected to grow to USD 16.34 billion in 2025, with a CAGR of 7.71%, reaching USD 23.78 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 15.23 billion
Estimated Year [2025] USD 16.34 billion
Forecast Year [2030] USD 23.78 billion
CAGR (%) 7.71%

The global prefilled syringes market is evolving at an unprecedented pace, marked by innovation and a robust drive toward enhanced patient care. Over recent years, the landscape has witnessed increased adoption of prefilled systems as they offer significant advantages over traditional vial-based dosing mechanisms. Prefilled syringes not only improve dosing accuracy but also minimize risks associated with contamination and medication errors.

In this dynamic market environment, stakeholders are paying closer attention to the dual imperatives of safety and efficiency. These devices are increasingly considered a critical component in healthcare delivery, as they address the logistical challenges posed by conventional methods. As research and development continue to fuel product innovation, manufacturers are now focusing on advancing syringe designs, materials, and manufacturing processes. The need for cost-effective yet technologically advanced solutions is driving the competitive spirit in this market.

This executive summary sets the stage by outlining the key market dynamics, technological advancements, and evolving trends that are redefining the future of prefilled syringes. The analysis navigates through diverse dimensions of the market, highlighting major influences that are shaping both the current scenario and future growth prospects.

Transformative Shifts in the Prefilled Syringes Market

Recent years have seen transformative shifts in the prefilled syringes market that underscore the sector's readiness to embrace change and innovation. The evolution of manufacturing technologies, coupled with advancements in drug delivery mechanisms, has led to significant improvements in syringe performance. In particular, innovations are addressing challenges related to sterility, usability, and environmental sustainability. The integration of cutting-edge materials has enhanced the compatibility of prefilled syringes with a broader range of medications, thereby expanding their utility across various therapeutic areas.

The shift towards needle-free and conventional technologies illustrates the industry's commitment to improving patient experience and safety. Manufacturers are investing in research that focuses on overcoming limitations of existing designs, thereby catalyzing a transition from traditional glass to advanced plastic and hybrid models. This progress is not only reflective of the demand for more user-friendly products but also highlights regulatory shifts. Regulatory bodies worldwide are endorsing enhanced safety protocols, prompting companies to upgrade their production lines and adhere to strict quality standards.

Furthermore, digital integration in manufacturing and supply chain management has enabled real-time monitoring and quality control, ensuring that the end products meet exacting specifications. The market's responsiveness to these transformative shifts is evident in the robust pipeline of product launches aimed at addressing emerging clinical requirements. As a result, the prefilled syringes market is moving from a primarily reactive stance to a proactive strategy geared towards anticipating future healthcare challenges.

Key Segmentation Insights in Prefilled Syringes

A detailed segmentation analysis of the prefilled syringes market reveals a complex framework driven by multiple factors. Firstly, an evaluation based on type identifies a dichotomy between conventional prefilled syringes and needle-free alternatives. These variations cater to different clinical needs and offer unique benefits depending on the intended application. In terms of material type, the market analysis distinguishes between syringes made from glass and those manufactured from plastic. Within the glass category, borosilicate glass and soda lime glass are examined, whereas the plastic category further bifurcates into crystal-clear polyethylene terephthalate and polypropylene options.

When the design dimension is considered, the differentiation lies between dual-chamber and single-chamber configurations. In dual-chamber designs, innovations such as burstable seals and dual-seal designs facilitate improved drug stability and ease of use, while single-chamber systems often feature collar-plunger integration and standard plunger designs to ensure consistency and reliability. The segmentation based on volume further categorizes the market into ranges such as 1 ml to 5 ml, volumes less than 1 ml, and those exceeding 5 ml, each set tailored to specific dosing requirements and patient demographics.

Additionally, the manufacturing method provides insights into the underlying technological processes, spanning blow-fill-seal technology, extrusion, and injection molding. This categorization highlights not only the diversity of production techniques but also the implications of these methods on scalability and product cost structures. Another critical segmentation dimension is the application space, where therapeutic areas such as oncology, rheumatology, and vaccination drive market demand. Oncology products are further analyzed by differentiating between chemotherapy drugs and immunotherapy approaches. Rheumatology segmented applications include anti-inflammatory injections and disease-modifying drugs, while the vaccination segment is dissected into adult, pediatric, and travel vaccination categories.

Lastly, distribution channel segmentation emphasizes the varied pathways through which these products reach end-users. Hospitals and clinics, online pharmacies, as well as retail pharmacies together comprise a dynamic network that supports the market's growth. Each of these segmentation dimensions paints a comprehensive picture of the market's multifaceted nature and highlights opportunities for targeted innovation and strategic investments.

Based on Type, market is studied across Conventional Prefilled Syringes and Needle-Free Prefilled Syringes.

Based on Material Type, market is studied across Glass and Plastic. The Glass is further studied across Borosilicate Glass and Soda Lime Glass. The Plastic is further studied across Crystal-clear Polyethylene Terephthalate and Polypropylene.

Based on Design, market is studied across Dual-Chamber and Single-Chamber. The Dual-Chamber is further studied across Burstable Seals and Dual-Seal Design. The Single-Chamber is further studied across Collar-Plunger Integration and Standard Plunger.

Based on Volume, market is studied across 1 ml - 5 ml, < 1 ml, and > 5 ml.

Based on Manufacturing Method, market is studied across Blow-Fill-Seal Technology, Extrusion, and Injection Molding.

Based on Application, market is studied across Oncology, Rheumatology, and Vaccination. The Oncology is further studied across Chemotherapy Drugs and Immunotherapy. The Rheumatology is further studied across Anti-inflammatory Injections and Disease Modifying Drugs. The Vaccination is further studied across Adult Vaccination, Pediatric Vaccination, and Travel Vaccination.

Based on Distribution Channel, market is studied across Hospitals & Clinics, Online Pharmacies, and Retail Pharmacies.

Key Regional Insights Across Major Global Markets

Geographical analysis of the prefilled syringes market reveals significant regional variances, with insights drawn from major markets such as the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, well-established healthcare infrastructures paired with rising demand for advanced drug delivery systems have fostered rapid market growth. The maturation of the market in this region is driven by both technological advancements and heightened regulatory scrutiny aimed at ensuring the highest quality standards.

In Europe, Middle East & Africa, stringent regulatory policies and a keen focus on patient safety complement the rapid integration of innovative syringe designs. These regions have demonstrated an evolving preference for both conventional and needle-free prefilled syringe systems, which are seamlessly integrated into contemporary healthcare practices.

Asia-Pacific, on the other hand, presents a vibrant and expanding market marked by significant investments in healthcare technology. Rapid industrialization, increasing healthcare awareness, and improving infrastructure collectively create a conducive environment for market penetration. The diversity of healthcare needs in this region is driving customization and localized manufacturing strategies, enabling manufacturers to tailor their product offerings effectively. Overall, these regional insights underscore the importance of adapting market strategies to regional strengths and challenges.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Major Companies Shaping the Prefilled Syringes Market

Consolidation and innovation in the prefilled syringes market are being propelled by a cadre of prominent companies. This competitive outlook includes established players such as AbbVie Inc. and AptarGroup, Inc., which have built a reputation for integrating high precision and innovative drug delivery solutions. Baxter International, Inc. and Becton, Dickinson and Company continue to strengthen their market positions through robust research and development, ensuring continuous improvement in syringe design and safety features.

Global firms like Boehringer Ingelheim Pharmaceuticals, Inc, Catalent, Inc. by Novo Holdings A/S, and Eli Lilly and Company have also significantly influenced market dynamics, leveraging expansive distribution networks and advanced manufacturing capabilities. In addition, F. Hoffmann-La Roche Ltd. and Fresenius Kabi AG are recognized for their commitments to quality and innovation, while Gerresheimer AG and GlaxoSmithKline plc reinforce market leadership through comprehensive product portfolios.

Janssen Pharmaceuticals, Inc. by Johnson & Johnson and Mylan N.V. by Viatris Inc. have made notable strides in aligning technological advancements with evolving consumer needs. Other influential companies including Nipro Europe Group Companies, Novartis AG, Pfizer, Inc., and Samsung Bioepis contribute to a diversified and resilient market structure. The sustained excellence of companies such as Sanofi S.A, SCHOTT Pharma, Shandong Weigao Group Medical Polymer Company Limited, SHL Medical AG, Stevanato Group, Terumo Medical Corporation, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services, Inc., and Ypsomed AG have further catalyzed market growth and innovation, all driving the industry forward with an unwavering commitment to quality and performance.

The report delves into recent significant developments in the Prefilled Syringes Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., AptarGroup, Inc., Baxter International, Inc., Becton, Dickinson and Company, Boehringer Ingelheim Pharmaceuticals, Inc, Catalent, Inc. by Novo Holdings A/S, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Fresenius Kabi AG, Gerresheimer AG, GlaxoSmithKline plc, Janssen Pharmaceuticals, Inc. by Johnson & Johnson, Mylan N.V. by Viatris Inc., Nipro Europe Group Companies, Novartis AG, Pfizer, Inc., Samsung Bioepis, Sanofi S.A, SCHOTT Pharma, Shandong Weigao Group Medical Polymer Company Limited, SHL Medical AG, Stevanato Group, Terumo Medical Corporation, Teva Pharmaceutical Industries Ltd., West Pharmaceutical Services, Inc., and Ypsomed AG. Actionable Recommendations for Market Leaders

To remain at the forefront of the prefilled syringes market, industry leaders should prioritize strategic investments in research and development to harness the latest technological advances and meet the rising demand for innovative drug delivery systems. An emphasis on sustainable and scalable manufacturing practices is essential. Investing in modern production techniques, such as blow-fill-seal and injection molding, not only streamlines operations but also ensures product integrity.

Additionally, companies should enhance collaboration with regulatory bodies to perfectly align with evolving safety standards, thus mitigating potential compliance issues. Embracing a multi-dimensional segmentation strategy that carefully considers product type, material attributes, design complexities, volume specifications, and therapeutic applications is critical for staying competitive. Leaders are encouraged to integrate comprehensive market intelligence and forecasting tools to better anticipate market shifts and consumer preferences.

Expanding distribution channels-particularly in rapidly growing regions such as Asia-Pacific-will be paramount. Strengthening digital partnerships and leveraging online platforms can effectively boost accessibility and overall market reach. By implementing these actionable recommendations, decision-makers can secure a competitive edge, drive operational efficiency, and meet the strategic challenges head-on in an increasingly dynamic marketplace.

Conclusion of the Prefilled Syringes Market Research

In conclusion, the comprehensive analysis of the prefilled syringes market highlights its rapid evolution driven by technological advancements, diversified segmentation, and strategic regional expansions. The market is being reshaped by significant transformative improvements that are addressing challenges related to usability, product safety, and cost efficiency. With the interplay of robust segmentation frameworks and an expansive range of applications across therapeutic areas, prefilled syringes are poised to play an integral part in modern healthcare delivery.

The findings underscore the compelling need for healthcare professionals and industry stakeholders to stay informed about emerging trends and continuously recalibrate their strategies to align with dynamic market demands. As innovation and regulatory evolutions continue to intersect, this report offers a roadmap for navigating future opportunities and challenges with confidence and strategic foresight.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing demand for self-administration of drugs and reducing medication errors
      • 5.1.1.2. Increasing prevalence of chronic diseases boosts demand for prefilled syringes in healthcare
      • 5.1.1.3. Rising vaccination initiatives and awareness
    • 5.1.2. Restraints
      • 5.1.2.1. Difficulties in the cold chain storage and transportation of prefilled syringes
    • 5.1.3. Opportunities
      • 5.1.3.1. Expansion of home healthcare services fuels the need for easy-to-use prefilled syringe solutions
      • 5.1.3.2. Rising healthcare awareness and expenditure in emerging markets
    • 5.1.4. Challenges
      • 5.1.4.1. Ensuring consistent quality and safety standards for prefilled syringes across different regions
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type : Higher proliferation of conventional prefilled syringes due to their established market presence
    • 5.2.2. Distribution Channel :Growing need for prefilled syringes in hospitals & clinics due to their precise dosage and safety features
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Prefilled Syringes Market, by Type

  • 6.1. Introduction
  • 6.2. Conventional Prefilled Syringes
  • 6.3. Needle-Free Prefilled Syringes

7. Prefilled Syringes Market, by Material Type

  • 7.1. Introduction
  • 7.2. Glass
    • 7.2.1. Borosilicate Glass
    • 7.2.2. Soda Lime Glass
  • 7.3. Plastic
    • 7.3.1. Crystal-clear Polyethylene Terephthalate
    • 7.3.2. Polypropylene

8. Prefilled Syringes Market, by Design

  • 8.1. Introduction
  • 8.2. Dual-Chamber
    • 8.2.1. Burstable Seals
    • 8.2.2. Dual-Seal Design
  • 8.3. Single-Chamber
    • 8.3.1. Collar-Plunger Integration
    • 8.3.2. Standard Plunger

9. Prefilled Syringes Market, by Volume

  • 9.1. Introduction
  • 9.2. 1 ml - 5 ml
  • 9.3. < 1 ml
  • 9.4. > 5 ml

10. Prefilled Syringes Market, by Manufacturing Method

  • 10.1. Introduction
  • 10.2. Blow-Fill-Seal Technology
  • 10.3. Extrusion
  • 10.4. Injection Molding

11. Prefilled Syringes Market, by Application

  • 11.1. Introduction
  • 11.2. Oncology
    • 11.2.1. Chemotherapy Drugs
    • 11.2.2. Immunotherapy
  • 11.3. Rheumatology
    • 11.3.1. Anti-inflammatory Injections
    • 11.3.2. Disease Modifying Drugs
  • 11.4. Vaccination
    • 11.4.1. Adult Vaccination
    • 11.4.2. Pediatric Vaccination
    • 11.4.3. Travel Vaccination

12. Prefilled Syringes Market, by Distribution Channel

  • 12.1. Introduction
  • 12.2. Hospitals & Clinics
  • 12.3. Online Pharmacies
  • 12.4. Retail Pharmacies

13. Americas Prefilled Syringes Market

  • 13.1. Introduction
  • 13.2. Argentina
  • 13.3. Brazil
  • 13.4. Canada
  • 13.5. Mexico
  • 13.6. United States

14. Asia-Pacific Prefilled Syringes Market

  • 14.1. Introduction
  • 14.2. Australia
  • 14.3. China
  • 14.4. India
  • 14.5. Indonesia
  • 14.6. Japan
  • 14.7. Malaysia
  • 14.8. Philippines
  • 14.9. Singapore
  • 14.10. South Korea
  • 14.11. Taiwan
  • 14.12. Thailand
  • 14.13. Vietnam

15. Europe, Middle East & Africa Prefilled Syringes Market

  • 15.1. Introduction
  • 15.2. Denmark
  • 15.3. Egypt
  • 15.4. Finland
  • 15.5. France
  • 15.6. Germany
  • 15.7. Israel
  • 15.8. Italy
  • 15.9. Netherlands
  • 15.10. Nigeria
  • 15.11. Norway
  • 15.12. Poland
  • 15.13. Qatar
  • 15.14. Russia
  • 15.15. Saudi Arabia
  • 15.16. South Africa
  • 15.17. Spain
  • 15.18. Sweden
  • 15.19. Switzerland
  • 15.20. Turkey
  • 15.21. United Arab Emirates
  • 15.22. United Kingdom

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Scenario Analysis
    • 16.3.1. BD expands production and innovation in prefillable syringes for biologics
    • 16.3.2. Bora Pharmaceuticals acquires Baltimore facility from Emergent BioSolutions to expand North American footprint and enhance prefilled syringe production
    • 16.3.3. SCHOTT Pharma and KORU Medical Systems collaborate to innovate large-volume subcutaneous infusion solutions
    • 16.3.4. ROVI to enhance market presence and revenue with new pre-filled syringe manufacturing agreement, focusing on convenience, safety, and sustainability
    • 16.3.5. Schott Pharma expands U.S. operations with new prefillable syringe facility boosting production capacity and market penetration
  • 16.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. AptarGroup, Inc.
  • 3. Baxter International, Inc.
  • 4. Becton, Dickinson and Company
  • 5. Boehringer Ingelheim Pharmaceuticals, Inc
  • 6. Catalent, Inc. by Novo Holdings A/S
  • 7. Eli Lilly and Company
  • 8. F. Hoffmann-La Roche Ltd.
  • 9. Fresenius Kabi AG
  • 10. Gerresheimer AG
  • 11. GlaxoSmithKline plc
  • 12. Janssen Pharmaceuticals, Inc. by Johnson & Johnson
  • 13. Mylan N.V. by Viatris Inc.
  • 14. Nipro Europe Group Companies
  • 15. Novartis AG
  • 16. Pfizer, Inc.
  • 17. Samsung Bioepis
  • 18. Sanofi S.A
  • 19. SCHOTT Pharma
  • 20. Shandong Weigao Group Medical Polymer Company Limited
  • 21. SHL Medical AG
  • 22. Stevanato Group
  • 23. Terumo Medical Corporation
  • 24. Teva Pharmaceutical Industries Ltd.
  • 25. West Pharmaceutical Services, Inc.
  • 26. Ypsomed AG

LIST OF FIGURES

  • FIGURE 1. PREFILLED SYRINGES MARKET MULTI-CURRENCY
  • FIGURE 2. PREFILLED SYRINGES MARKET MULTI-LANGUAGE
  • FIGURE 3. PREFILLED SYRINGES MARKET RESEARCH PROCESS
  • FIGURE 4. PREFILLED SYRINGES MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL PREFILLED SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 19. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
  • FIGURE 21. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 25. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 27. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 28. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 29. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 30. PREFILLED SYRINGES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 31. PREFILLED SYRINGES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. PREFILLED SYRINGES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL PREFILLED SYRINGES MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. PREFILLED SYRINGES MARKET DYNAMICS
  • TABLE 7. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY CONVENTIONAL PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY NEEDLE-FREE PREFILLED SYRINGES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY GLASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY BOROSILICATE GLASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY SODA LIME GLASS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY CRYSTAL-CLEAR POLYETHYLENE TEREPHTHALATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY POLYPROPYLENE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY BURSTABLE SEALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DUAL-SEAL DESIGN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY COLLAR-PLUNGER INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY STANDARD PLUNGER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY 1 ML - 5 ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY < 1 ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY > 5 ML, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY BLOW-FILL-SEAL TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY EXTRUSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY INJECTION MOLDING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY CHEMOTHERAPY DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY IMMUNOTHERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY ANTI-INFLAMMATORY INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DISEASE MODIFYING DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY ADULT VACCINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY PEDIATRIC VACCINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY TRAVEL VACCINATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 52. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 53. GLOBAL PREFILLED SYRINGES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 63. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 65. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 66. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 67. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. AMERICAS PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 74. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 75. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 76. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 77. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 78. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 80. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 81. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 82. ARGENTINA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 86. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 87. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 88. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 89. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 90. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 91. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 92. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 94. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 95. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 96. BRAZIL PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. CANADA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. CANADA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. CANADA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 100. CANADA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 101. CANADA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 102. CANADA PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 103. CANADA PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 104. CANADA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 105. CANADA PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 106. CANADA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. CANADA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. CANADA PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 109. CANADA PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 110. CANADA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 111. MEXICO PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. MEXICO PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. MEXICO PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 114. MEXICO PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 115. MEXICO PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 116. MEXICO PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 117. MEXICO PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 118. MEXICO PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 119. MEXICO PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 120. MEXICO PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. MEXICO PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 122. MEXICO PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. MEXICO PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 124. MEXICO PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 128. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 129. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 130. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 131. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 132. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 133. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 134. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 136. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED STATES PREFILLED SYRINGES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 155. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 158. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 159. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 160. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 161. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 162. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 163. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 164. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 166. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 167. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 168. AUSTRALIA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. CHINA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. CHINA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. CHINA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 172. CHINA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 173. CHINA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 174. CHINA PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 175. CHINA PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 176. CHINA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 177. CHINA PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 178. CHINA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. CHINA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 180. CHINA PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 181. CHINA PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 182. CHINA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 183. INDIA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. INDIA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. INDIA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 186. INDIA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 187. INDIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 188. INDIA PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 189. INDIA PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 190. INDIA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 191. INDIA PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 192. INDIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. INDIA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. INDIA PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 195. INDIA PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 196. INDIA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 197. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 200. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 201. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 202. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 203. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 204. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 205. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 206. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 208. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 210. INDONESIA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 211. JAPAN PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. JAPAN PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. JAPAN PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 214. JAPAN PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 215. JAPAN PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 216. JAPAN PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 217. JAPAN PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 218. JAPAN PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 219. JAPAN PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 220. JAPAN PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 221. JAPAN PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 222. JAPAN PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 223. JAPAN PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 224. JAPAN PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 225. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 228. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 229. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 230. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 231. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 232. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 233. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 234. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 236. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 237. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 238. MALAYSIA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 239. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 241. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 242. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 243. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 244. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 245. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 246. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 247. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 248. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 249. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 250. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 251. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 252. PHILIPPINES PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 253. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 256. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 257. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 258. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 259. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 260. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 261. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 262. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 263. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 264. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 265. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 266. SINGAPORE PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 267. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 269. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 270. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 271. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 272. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 273. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 274. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 275. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 276. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 277. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 278. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 279. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 280. SOUTH KOREA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 281. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 283. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 284. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 285. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 286. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 287. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 288. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 289. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 290. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 292. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 293. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 294. TAIWAN PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 295. THAILAND PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. THAILAND PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 297. THAILAND PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 298. THAILAND PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 299. THAILAND PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 300. THAILAND PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 301. THAILAND PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 302. THAILAND PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 303. THAILAND PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 304. THAILAND PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 305. THAILAND PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 306. THAILAND PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 307. THAILAND PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 308. THAILAND PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 309. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 310. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 311. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 312. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 313. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 314. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 315. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 316. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 317. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 318. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 319. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 320. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 321. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 322. VIETNAM PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 323. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 324. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 325. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 326. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 327. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 328. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 329. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 330. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 331. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 332. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 333. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 334. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 335. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 336. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 337. EUROPE, MIDDLE EAST & AFRICA PREFILLED SYRINGES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 338. DENMARK PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 339. DENMARK PREFILLED SYRINGES MARKET SIZE, BY MATERIAL TYPE, 2018-2030 (USD MILLION)
  • TABLE 340. DENMARK PREFILLED SYRINGES MARKET SIZE, BY GLASS, 2018-2030 (USD MILLION)
  • TABLE 341. DENMARK PREFILLED SYRINGES MARKET SIZE, BY PLASTIC, 2018-2030 (USD MILLION)
  • TABLE 342. DENMARK PREFILLED SYRINGES MARKET SIZE, BY DESIGN, 2018-2030 (USD MILLION)
  • TABLE 343. DENMARK PREFILLED SYRINGES MARKET SIZE, BY DUAL-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 344. DENMARK PREFILLED SYRINGES MARKET SIZE, BY SINGLE-CHAMBER, 2018-2030 (USD MILLION)
  • TABLE 345. DENMARK PREFILLED SYRINGES MARKET SIZE, BY VOLUME, 2018-2030 (USD MILLION)
  • TABLE 346. DENMARK PREFILLED SYRINGES MARKET SIZE, BY MANUFACTURING METHOD, 2018-2030 (USD MILLION)
  • TABLE 347. DENMARK PREFILLED SYRINGES MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 348. DENMARK PREFILLED SYRINGES MARKET SIZE, BY ONCOLOGY, 2018-2030 (USD MILLION)
  • TABLE 349. DENMARK PREFILLED SYRINGES MARKET SIZE, BY RHEUMATOLOGY, 2018-2030 (USD MILLION)
  • TABLE 350. DENMARK PREFILLED SYRINGES MARKET SIZE, BY VACCINATION, 2018-2030 (USD MILLION)
  • TABLE 351. DENMARK PREFILLED SYRINGES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 352. EGYPT PREFILLED SYRINGES MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)

T